To enhance productivity and accelerate drug discovery timelines for our clients, the in-vitro biology group at Kemxtree is in the process of adopting an array of assay platforms.  The in-vitro biology group aims to have the capability to measure biological activity across a broad spectrum of drug target classes ranging from GPCRs and Kinases to eventually cover ion channels.

Working in concert with medicinal chemistry teams, the in vitro biology aims to expedite lead generation, target validation and lead optimization resulting in high quality clinical drug candidates in a timely fashion